Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Breast Cancer

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 228 articles:
HTML format



Single Articles


    January 2022
  1. MASCIA F, Mazo I, Alterovitz WL, Karagiannis K, et al
    In search of autophagy biomarkers in breast cancer: Receptor status and drug agnostic transcriptional changes during autophagy flux in cell lines.
    PLoS One. 2022;17:e0262134.
    PubMed     Abstract available


  2. MOHAMED EA, Rashed EA, Gaber T, Karam O, et al
    Deep learning model for fully automated breast cancer detection system from thermograms.
    PLoS One. 2022;17:e0262349.
    PubMed     Abstract available


  3. HUTAJULU SH, Prabandari YS, Bintoro BS, Wiranata JA, et al
    Delays in the presentation and diagnosis of women with breast cancer in Yogyakarta, Indonesia: A retrospective observational study.
    PLoS One. 2022;17:e0262468.
    PubMed     Abstract available


  4. ZAHRAN AM, Rayan A, Zahran ZAM, Mohamed WMY, et al
    Overexpression of PD-1 and CD39 in tumor-infiltrating lymphocytes compared with peripheral blood lymphocytes in triple-negative breast cancer.
    PLoS One. 2022;17:e0262650.
    PubMed     Abstract available


  5. HOZHABRI H, Ghasemi Dehkohneh RS, Razavi SM, Razavi SM, et al
    Comparative analysis of protein-protein interaction networks in metastatic breast cancer.
    PLoS One. 2022;17:e0260584.
    PubMed     Abstract available


  6. SILVA DAS
    Hospitalization and ambulatory costs related to breast cancer due to physical inactivity in the Brazilian state capitals.
    PLoS One. 2022;17:e0261019.
    PubMed     Abstract available


  7. CAO X, Li Y, Wang Y, Yu T, et al
    Curcumin suppresses tumorigenesis by ferroptosis in breast cancer.
    PLoS One. 2022;17:e0261370.
    PubMed     Abstract available


    January 2021
  8. MOUSTAFA D, Elwahed MRA, Elsaid HH, Parvin JD, et al
    Modulation of Early Mitotic Inhibitor 1 (EMI1) depletion on the sensitivity of PARP inhibitors in BRCA1 mutated triple-negative breast cancer cells.
    PLoS One. 2021;16:e0235025.
    PubMed     Abstract available


  9. GALILI B, Tekpli X, Kristensen VN, Yakhini Z, et al
    Efficient gene expression signature for a breast cancer immuno-subtype.
    PLoS One. 2021;16:e0245215.
    PubMed     Abstract available


  10. BHANDARI D, Shibanuma A, Kiriya J, Hirachan S, et al
    Factors associated with breast cancer screening intention in Kathmandu Valley, Nepal.
    PLoS One. 2021;16:e0245856.
    PubMed     Abstract available


  11. ALLMAN R, Spaeth E, Lai J, Gross SJ, et al
    A streamlined model for use in clinical breast cancer risk assessment maintains predictive power and is further improved with inclusion of a polygenic risk score.
    PLoS One. 2021;16:e0245375.
    PubMed     Abstract available


  12. SAFI N, Saunders C, Hayen A, Anazodo A, et al
    Gestational breast cancer in New South Wales: A population-based linkage study of incidence, management, and outcomes.
    PLoS One. 2021;16:e0245493.
    PubMed     Abstract available


  13. ELLINGJORD-DALE M, Papadimitriou N, Katsoulis M, Yee C, et al
    Coffee consumption and risk of breast cancer: A Mendelian randomization study.
    PLoS One. 2021;16:e0236904.
    PubMed     Abstract available


  14. SALGUERO-ARANDA C, Sancho-Mensat D, Canals-Lorente B, Sultan S, et al
    Expression of Concern: STAT6 knockdown using multiple siRNA sequences inhibits proliferation and induces apoptosis of human colorectal and breast cancer cell lines.
    PLoS One. 2021;16:e0246415.
    PubMed    


  15. NIEF C, Morhard R, Chelales E, Adrianzen Alvarez D, et al
    Polymer-assisted intratumoral delivery of ethanol: Preclinical investigation of safety and efficacy in a murine breast cancer model.
    PLoS One. 2021;16:e0234535.
    PubMed     Abstract available


  16. BOUJEMAA M, Hamdi Y, Mejri N, Romdhane L, et al
    Germline copy number variations in BRCA1/2 negative families: Role in the molecular etiology of hereditary breast cancer in Tunisia.
    PLoS One. 2021;16:e0245362.
    PubMed     Abstract available


  17. CHIN CH, Tseng LM, Chao TC, Wang TJ, et al
    Self-care as a mediator between symptom-management self-efficacy and quality of life in women with breast cancer.
    PLoS One. 2021;16:e0246430.
    PubMed     Abstract available


  18. XU S, Wang H, Liu Y, Zhang C, et al
    Hair chemicals may increase breast cancer risk: A meta-analysis of 210319 subjects from 14 studies.
    PLoS One. 2021;16:e0243792.
    PubMed     Abstract available


  19. OLIVEIRA NPD, Cancela MC, Martins LFL, de Souza DLB, et al
    Spatial distribution of advanced stage diagnosis and mortality of breast cancer: Socioeconomic and health service offer inequalities in Brazil.
    PLoS One. 2021;16:e0246333.
    PubMed     Abstract available


  20. ZHOU Y, Yuan Y, Li L, Wang X, et al
    HER2-intronic miR-4728-5p facilitates HER2 expression and accelerates cell proliferation and migration by targeting EBP1 in breast cancer.
    PLoS One. 2021;16:e0245832.
    PubMed     Abstract available


  21. HONG JH, Goo JM, Moon HG, Chang JM, et al
    Usefulness of staging chest-CT in patients with operable breast cancer.
    PLoS One. 2021;16:e0246563.
    PubMed     Abstract available


  22. BAR H, Bang S
    A mixture model to detect edges in sparse co-expression graphs with an application for comparing breast cancer subtypes.
    PLoS One. 2021;16:e0246945.
    PubMed     Abstract available


  23. ZHANG H, Zhang LQ, Yang CC, Li J, et al
    The high expression of NUDT5 indicates poor prognosis of breast cancer by modulating AKT / Cyclin D signaling.
    PLoS One. 2021;16:e0245876.
    PubMed     Abstract available


  24. SCIMONE MT, Krishnamurthy S, Maguluri G, Preda D, et al
    Assessment of breast cancer surgical margins with multimodal optical microscopy: A feasibility clinical study.
    PLoS One. 2021;16:e0245334.
    PubMed     Abstract available


  25. YANAI H, Yoshikawa K, Ishida M, Tsuta K, et al
    Presence of myxoid stromal change and fibrotic focus in pathological examination are prognostic factors of triple-negative breast cancer: Results from a retrospective single-center study.
    PLoS One. 2021;16:e0245725.
    PubMed     Abstract available


  26. ASADI M, Ahmadi N, Ahmadvand S, Jafari AA, et al
    Investigation of olfactory receptor family 51 subfamily j member 1 (OR51J1) gene susceptibility as a potential breast cancer-associated biomarker.
    PLoS One. 2021;16:e0246752.
    PubMed     Abstract available


  27. PHAM DX, Ho TH, Bui TD, Ho-Pham LT, et al
    Trends in breast cancer incidence in Ho Chi Minh City 1996-2015: A registry-based study.
    PLoS One. 2021;16:e0246800.
    PubMed     Abstract available


  28. JACKSON C, Freeman ALJ, Szlamka Z, Spiegelhalter DJ, et al
    The adverse effects of bisphosphonates in breast cancer: A systematic review and network meta-analysis.
    PLoS One. 2021;16:e0246441.
    PubMed     Abstract available


  29. SANDOVAL RL, Leite ACR, Barbalho DM, Assad DX, et al
    Germline molecular data in hereditary breast cancer in Brazil: Lessons from a large single-center analysis.
    PLoS One. 2021;16:e0247363.
    PubMed     Abstract available


  30. NAFIE E, Lolarga J, Lam B, Guo J, et al
    Harmine inhibits breast cancer cell migration and invasion by inducing the degradation of Twist1.
    PLoS One. 2021;16:e0247652.
    PubMed     Abstract available


  31. WANANDI SI, Limanto A, Yunita E, Syahrani RA, et al
    Correction: In silico and in vitro studies on the anti-cancer activity of andrographolide targeting survivin in human breast cancer stem cells.
    PLoS One. 2021;16:e0247694.
    PubMed     Abstract available


  32. AL-SALEH K, Salah T, Arafah M, Husain S, et al
    Prognostic significance of estrogen, progesterone and HER2 receptors' status conversion following neoadjuvant chemotherapy in patients with locally advanced breast cancer: Results from a tertiary Cancer Center in Saudi Arabia.
    PLoS One. 2021;16:e0247802.
    PubMed     Abstract available


  33. LUO HB, Liu YY, Wang CH, Qing HM, et al
    Radiomic features of axillary lymph nodes based on pharmacokinetic modeling DCE-MRI allow preoperative diagnosis of their metastatic status in breast cancer.
    PLoS One. 2021;16:e0247074.
    PubMed     Abstract available


  34. OLSEN KS, Holden M, Thalabard JC, Rasmussen Busund LT, et al
    Global blood gene expression profiles following a breast cancer diagnosis-Clinical follow-up in the NOWAC post-genome cohort.
    PLoS One. 2021;16:e0246650.
    PubMed     Abstract available


  35. RAHIMZADEH S, Burczynska B, Ahmadvand A, Sheidaei A, et al
    Geographical and socioeconomic inequalities in female breast cancer incidence and mortality in Iran: A Bayesian spatial analysis of registry data.
    PLoS One. 2021;16:e0248723.
    PubMed     Abstract available


  36. GRANQVIST V, Holmgren C, Larsson C
    Induction of interferon-beta and interferon signaling by TRAIL and Smac mimetics via caspase-8 in breast cancer cells.
    PLoS One. 2021;16:e0248175.
    PubMed     Abstract available


  37. UMAMAHESWARAN G, Kadambari D, Muthuvel SK, Kumar NAN, et al
    Polymorphisms of T- cell leukemia 1A gene loci are not related to the development of adjuvant letrozole-induced adverse events in breast cancer.
    PLoS One. 2021;16:e0247989.
    PubMed     Abstract available


  38. LOURO J, Roman M, Posso M, Vazquez I, et al
    Developing and validating an individualized breast cancer risk prediction model for women attending breast cancer screening.
    PLoS One. 2021;16:e0248930.
    PubMed     Abstract available


  39. KOOP Y, Dobbe L, Maas AHEM, van Spronsen DJ, et al
    Oncology professionals' perspectives towards cardiac surveillance in breast cancer patients with high cardiotoxicity risk: A qualitative study.
    PLoS One. 2021;16:e0249067.
    PubMed     Abstract available


  40. GONG Z, Chen J, Wang J, Liu S, et al
    Differential methylation and expression patterns of microRNAs in relation to breast cancer subtypes among American women of African and European ancestry.
    PLoS One. 2021;16:e0249229.
    PubMed     Abstract available


  41. KLINGEN TA, Chen Y, Aas H, Wik E, et al
    Fibulin-2 expression associates with vascular invasion and patient survival in breast cancer.
    PLoS One. 2021;16:e0249767.
    PubMed     Abstract available


  42. MADUT A, Fuchsova V, Man H, Askar S, et al
    Increased prevalence of obstructive sleep apnea in women diagnosed with endometrial or breast cancer.
    PLoS One. 2021;16:e0249099.
    PubMed     Abstract available


  43. AGUIRRE-CAMACHO A, Hidalgo B, Gonzalez-Cuevas G
    Fear of breast cancer among young Spanish women: Factor structure and psychometric properties of the Champion breast cancer fear scale.
    PLoS One. 2021;16:e0249562.
    PubMed     Abstract available


  44. LI J, Zhou Z, Dong J, Fu Y, et al
    Predicting breast cancer 5-year survival using machine learning: A systematic review.
    PLoS One. 2021;16:e0250370.
    PubMed     Abstract available


  45. CHAINITIKUN S, Espinosa Fernandez JR, Long JP, Iwase T, et al
    Pathological complete response of adding targeted therapy to neoadjuvant chemotherapy for inflammatory breast cancer: A systematic review.
    PLoS One. 2021;16:e0250057.
    PubMed     Abstract available


  46. NGUYEN HOANG AT, Hoe KL, Lee SJ
    CSNK1G2 differently sensitizes tamoxifen-induced decrease in PI3K/AKT/mTOR/S6K and ERK signaling according to the estrogen receptor existence in breast cancer cells.
    PLoS One. 2021;16:e0246264.
    PubMed     Abstract available


  47. NISHIDA-FUKUDA H, Tokuhiro K, Ando Y, Matsushita H, et al
    Evaluation of the antiproliferative effects of the HASPIN inhibitor CHR-6494 in breast cancer cell lines.
    PLoS One. 2021;16:e0249912.
    PubMed     Abstract available


  48. NERSISYAN S, Galatenko A, Galatenko V, Shkurnikov M, et al
    miRGTF-net: Integrative miRNA-gene-TF network analysis reveals key drivers of breast cancer recurrence.
    PLoS One. 2021;16:e0249424.
    PubMed     Abstract available


  49. SATPATHY S, Patra A, Hussain MD, Kazi M, et al
    A fraction of Pueraria tuberosa extract, rich in antioxidant compounds, alleviates ovariectomized-induced osteoporosis in rats and inhibits growth of breast and ovarian cancer cells.
    PLoS One. 2021;16:e0240068.
    PubMed     Abstract available


  50. HSIANG YP, Wang YT, Huang KS, Huang TY, et al
    Facile production of chlorophyllides using recombinant CrCLH1 and their cytotoxicity towards multidrug resistant breast cancer cell lines.
    PLoS One. 2021;16:e0250565.
    PubMed     Abstract available


  51. YANG C, He XF
    Evaluation of association studies and a systematic review and meta-analysis of CYP1A1 T3801C and A2455G polymorphisms in breast cancer risk.
    PLoS One. 2021;16:e0249632.
    PubMed     Abstract available


  52. AHMED SH, Espinoza-Sanchez NA, El-Damen A, Fahim SA, et al
    Small extracellular vesicle-encapsulated miR-181b-5p, miR-222-3p and let-7a-5p: Next generation plasma biopsy-based diagnostic biomarkers for inflammatory breast cancer.
    PLoS One. 2021;16:e0250642.
    PubMed     Abstract available


  53. HO PJ, Yeoh YS, Miao H, Lim SH, et al
    Cohort profile: The Singapore Breast Cancer Cohort (SGBCC), a multi-center breast cancer cohort for evaluation of phenotypic risk factors and genetic markers.
    PLoS One. 2021;16:e0250102.
    PubMed     Abstract available


  54. TOKUNAGA H, Iida K, Hozawa A, Ogishima S, et al
    Novel candidates of pathogenic variants of the BRCA1 and BRCA2 genes from a dataset of 3,552 Japanese whole genomes (3.5KJPNv2).
    PLoS One. 2021;16:e0236907.
    PubMed     Abstract available


  55. HOLTDIRK F, Mehnert A, Weiss M, Mayer J, et al
    Results of the Optimune trial: A randomized controlled trial evaluating a novel Internet intervention for breast cancer survivors.
    PLoS One. 2021;16:e0251276.
    PubMed     Abstract available


  56. VIJAYASARVESWARI V, Andrew AM, Jusoh M, Ahmad RB, et al
    Correction: Multi-stage feature selection (MSFS) algorithm for UWB-based early breast cancer size prediction.
    PLoS One. 2021;16:e0251679.
    PubMed     Abstract available


  57. ELOBAID Y, Aamir M, Grivna M, Suliman A, et al
    Breast cancer survival and its prognostic factors in the United Arab Emirates: A retrospective study.
    PLoS One. 2021;16:e0251118.
    PubMed     Abstract available


  58. PILLAI SG, Siddappa CM, Ma C, Snider J, et al
    A microfluidic-based filtration system to enrich for bone marrow disseminated tumor cells from breast cancer patients.
    PLoS One. 2021;16:e0246139.
    PubMed     Abstract available


  59. SAKATA-MATSUZAWA M, Denda-Nagai K, Fujihira H, Noji M, et al
    Glycans unique to the relapse-prone subset within triple-negative breast cancer as revealed by lectin array-based analysis of surgical specimens.
    PLoS One. 2021;16:e0250747.
    PubMed     Abstract available


  60. CHA YJ, Kim D, Bae SJ, Ahn SG, et al
    The association between the expression of nuclear Yes-associated protein 1 (YAP1) and p53 protein expression profile in breast cancer patients.
    PLoS One. 2021;16:e0250986.
    PubMed     Abstract available


  61. RAGO M, Placidi L, Polsoni M, Rambaldi G, et al
    Evaluation of a generalized knowledge-based planning performance for VMAT irradiation of breast and locoregional lymph nodes-Internal mammary and/or supraclavicular regions.
    PLoS One. 2021;16:e0245305.
    PubMed     Abstract available


  62. YAMAMURO M, Asai Y, Hashimoto N, Yasuda N, et al
    The effect of breast density on the missed lesion rate in screening digital mammography determined using an adjustable-density breast phantom tailored to Japanese women.
    PLoS One. 2021;16:e0245060.
    PubMed     Abstract available


  63. LEE SB, Kim H, Kim J, Chung IY, et al
    Prognosis according to clinical and pathologic lymph node status in breast cancer patients who underwent sentinel lymph node biopsy alone after neoadjuvant therapy.
    PLoS One. 2021;16:e0251597.
    PubMed     Abstract available


  64. MA S, Shepard DS, Ritter GA, Martell RE, et al
    Cost sharing for breast cancer hormone therapy: How do dual eligible patients' copayment impact adherence.
    PLoS One. 2021;16:e0250967.
    PubMed     Abstract available


  65. VELAZQUEZ FN, Zhang L, Viscardi V, Trocchia C, et al
    Loss of sphingosine kinase 1 increases lung metastases in the MMTV-PyMT mouse model of breast cancer.
    PLoS One. 2021;16:e0252311.
    PubMed     Abstract available


  66. KIM HS, Kim MG, Min KW, Jung US, et al
    High MMP-11 expression associated with low CD8+ T cells decreases the survival rate in patients with breast cancer.
    PLoS One. 2021;16:e0252052.
    PubMed     Abstract available


  67. NG DY, Tudor Car L, Ng MJM, Lu J, et al
    Identifying barriers to early presentation in patients with locally advanced breast cancer (LABC) in Northern Singapore: Qualitative study.
    PLoS One. 2021;16:e0252008.
    PubMed     Abstract available


  68. YOSHIKAWA K, Ishida M, Yanai H, Tsuta K, et al
    Immunohistochemical analysis of CD155 expression in triple-negative breast cancer patients.
    PLoS One. 2021;16:e0253176.
    PubMed     Abstract available


  69. LEE J, Kang BJ, Kim SH
    Usefulness of postoperative surveillance MR for women after breast-conservation therapy: Focusing on MR features of early and late recurrent breast cancer.
    PLoS One. 2021;16:e0252476.
    PubMed     Abstract available


  70. AKLILU S, Bain C, Bansil P, de Sanjose S, et al
    Evaluation of diagnostic ultrasound use in a breast cancer detection strategy in Northern Peru.
    PLoS One. 2021;16:e0252902.
    PubMed     Abstract available


  71. PODUVAL D, Sichmanova Z, Straume AH, Lonning PE, et al
    Correction: The novel microRNAs hsa-miR-nov7 and hsa-miR-nov3 are over-expressed in locally advanced breast cancer.
    PLoS One. 2021;16:e0253361.
    PubMed     Abstract available


  72. KANG Z, Chen S, Shi L, He Y, et al
    Predictors of heart and lung dose in left-sided breast cancer treated with VMAT relative to 3D-CRT: A retrospective study.
    PLoS One. 2021;16:e0252552.
    PubMed     Abstract available


  73. WATANABE T, Oba T, Tanimoto K, Shibata T, et al
    Tamoxifen resistance alters sensitivity to 5-fluorouracil in a subset of estrogen receptor-positive breast cancer.
    PLoS One. 2021;16:e0252822.
    PubMed     Abstract available


  74. AL-KEILANI MS, Elstaty RI, Alqudah MA, Alkhateeb AM, et al
    Immunohistochemical expression of substance P in breast cancer and its association with prognostic parameters and Ki-67 index.
    PLoS One. 2021;16:e0252616.
    PubMed     Abstract available


  75. ZHU L, Cui K, Weng L, Yu P, et al
    A panel of 8-lncRNA predicts prognosis of breast cancer patients and migration of breast cancer cells.
    PLoS One. 2021;16:e0249174.
    PubMed     Abstract available


  76. DING H, Buzzard GW, Huang S, Sehorn MG, et al
    MICA-G129R: A bifunctional fusion protein increases PRLR-positive breast cancer cell death in co-culture with natural killer cells.
    PLoS One. 2021;16:e0252662.
    PubMed     Abstract available



  77. Retraction: AIB1 Cooperates with ERalpha to Promote Epithelial Mesenchymal Transition in Breast Cancer through SNAI1 Activation.
    PLoS One. 2021;16:e0252791.
    PubMed    


  78. OSEI-AFRIYIE S, Addae AK, Oppong S, Amu H, et al
    Breast cancer awareness, risk factors and screening practices among future health professionals in Ghana: A cross-sectional study.
    PLoS One. 2021;16:e0253373.
    PubMed     Abstract available


  79. HSU SN, Hui EWE, Liu M, Wu D, et al
    Revealing nuclear receptor hub modules from Basal-like breast cancer expression networks.
    PLoS One. 2021;16:e0252901.
    PubMed     Abstract available


  80. SALAS M, Henderson M, Sundararajan M, Tu N, et al
    Use of comorbidity indices in patients with any cancer, breast cancer, and human epidermal growth factor receptor-2-positive breast cancer: A systematic review.
    PLoS One. 2021;16:e0252925.
    PubMed     Abstract available


  81. ALMUHTASEB MIA, Alby F, Zucchermaglio C, Fatigante M, et al
    Social support for breast cancer patients in the occupied Palestinian territory.
    PLoS One. 2021;16:e0252608.
    PubMed     Abstract available


  82. WIELEMA M, Sijens PE, Dijkstra H, De Bock GH, et al
    Diffusion weighted imaging of the breast: Performance of standardized breast tumor tissue selection methods in clinical decision making.
    PLoS One. 2021;16:e0245930.
    PubMed     Abstract available


  83. VIVES N, Farre A, Ibanez-Sanz G, Vidal C, et al
    Text messaging as a tool to improve cancer screening programs (M-TICS Study): A randomized controlled trial protocol.
    PLoS One. 2021;16:e0245806.
    PubMed     Abstract available


  84. LI Z, Zhang J, Zou W, Xu Q, et al
    The methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism is associated with breast cancer subtype susceptibility in southwestern China.
    PLoS One. 2021;16:e0254267.
    PubMed     Abstract available


  85. KENNEY J, Ndoye A, Lamar JM, DiPersio CM, et al
    Comparative use of CRISPR and RNAi to modulate integrin alpha3beta1 in triple negative breast cancer cells reveals that some pro-invasive/pro-metastatic alpha3beta1 functions are independent of global regulation of the transcriptome.
    PLoS One. 2021;16:e0254714.
    PubMed     Abstract available


  86. YANG J, Virostko J, Hormuth DA 2nd, Liu J, et al
    An experimental-mathematical approach to predict tumor cell growth as a function of glucose availability in breast cancer cell lines.
    PLoS One. 2021;16:e0240765.
    PubMed     Abstract available


  87. KIM H, Kwon S, Son SM, Jeong E, et al
    Tailored approach to the choice of long-term vascular access in breast cancer patients.
    PLoS One. 2021;16:e0255004.
    PubMed     Abstract available


  88. LOTHONG M, Sakares W, Rojsitthisak P, Tanikawa C, et al
    Collagen XVII inhibits breast cancer cell proliferation and growth through deactivation of the AKT/mTOR signaling pathway.
    PLoS One. 2021;16:e0255179.
    PubMed     Abstract available


  89. RATH S, Elamarthi P, Parab P, Gulia S, et al
    Efficacy and safety of palbociclib and ribociclib in patients with estrogen and/or progesterone receptor positive, HER2 receptor negative metastatic breast cancer in routine clinical practice.
    PLoS One. 2021;16:e0253722.
    PubMed     Abstract available


  90. KING L, Flaus A, Holian E, Golden A, et al
    Survival outcomes are associated with genomic instability in luminal breast cancers.
    PLoS One. 2021;16:e0245042.
    PubMed     Abstract available


  91. KIM JJ, Liang W, Kang CC, Pegram MD, et al
    Single-cell immunoblotting resolves estrogen receptor-alpha isoforms in breast cancer.
    PLoS One. 2021;16:e0254783.
    PubMed     Abstract available


  92. AHMED F, Adnan M, Malik A, Tariq S, et al
    Perception of breast cancer risk factors: Dysregulation of TGF-beta/miRNA axis in Pakistani females.
    PLoS One. 2021;16:e0255243.
    PubMed     Abstract available


  93. DANTAS DE ARAUJO SANTOS CAMARG, Dos Santos J, Simoes TC, Carvalho JBL, et al
    Mortality due to breast cancer in a region of high socioeconomic vulnerability in Brazil: Analysis of the effect of age-period and cohort.
    PLoS One. 2021;16:e0255935.
    PubMed     Abstract available


  94. NORDIN FJ, Pearanpan L, Chan KM, Kumolosasi E, et al
    Immunomodulatory potential of Clinacanthus nutans extracts in the co-culture of triple-negative breast cancer cells, MDA-MB-231, and THP-1 macrophages.
    PLoS One. 2021;16:e0256012.
    PubMed     Abstract available


  95. ASTARITA EM, Maloney SM, Hoover CA, Berkeley BJ, et al
    Adenomatous Polyposis Coli loss controls cell cycle regulators and response to paclitaxel in MDA-MB-157 metaplastic breast cancer cells.
    PLoS One. 2021;16:e0255738.
    PubMed     Abstract available


  96. SUN Z, Nyberg R, Wu Y, Bernard B, et al
    Developing an enhanced 7-color multiplex IHC protocol to dissect immune infiltration in human cancers.
    PLoS One. 2021;16:e0247238.
    PubMed     Abstract available


  97. PORCIELLO G, Montagnese C, Crispo A, Grimaldi M, et al
    Correction: Mediterranean diet and quality of life in women treated for breast cancer: A baseline analysis of DEDiCa multicentre trial.
    PLoS One. 2021;16:e0256944.
    PubMed     Abstract available


  98. HEENAYE-MAMODE KHAN M, Boodoo-Jahangeer N, Dullull W, Nathire S, et al
    Multi- class classification of breast cancer abnormalities using Deep Convolutional Neural Network (CNN).
    PLoS One. 2021;16:e0256500.
    PubMed     Abstract available


  99. ARNEJA J, Brooks JD
    The impact of chronic comorbidities at the time of breast cancer diagnosis on quality of life, and emotional health following treatment in Canada.
    PLoS One. 2021;16:e0256536.
    PubMed     Abstract available


  100. AHN HS, Kim SH, Kim JY, Park CS, et al
    Image quality and diagnostic value of diffusion-weighted breast magnetic resonance imaging: Comparison of acquired and computed images.
    PLoS One. 2021;16:e0247379.
    PubMed     Abstract available


  101. XIA LY, Xu WY, Hu QL
    The different outcomes between breast-conserving surgery plus radiotherapy and mastectomy in metaplastic breast cancer: A population-based study.
    PLoS One. 2021;16:e0256893.
    PubMed     Abstract available


  102. JANK P, Gehlhaar C, Lederer B, Fontanella C, et al
    Correction: MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial.
    PLoS One. 2021;16:e0257142.
    PubMed     Abstract available


  103. WOO J, Kim JB, Cho T, Yoo EH, et al
    Selenium inhibits growth of trastuzumab-resistant human breast cancer cells via downregulation of Akt and beclin-1.
    PLoS One. 2021;16:e0257298.
    PubMed     Abstract available


  104. ALAM NE, Islam MS, Ullah H, Molla MT, et al
    Evaluation of knowledge, awareness and attitudes towards breast cancer risk factors and early detection among females in Bangladesh: A hospital based cross-sectional study.
    PLoS One. 2021;16:e0257271.
    PubMed     Abstract available


  105. TESHOME B, Trabitzsch J, Afework T, Addissie A, et al
    Perceived barriers to timely treatment initiation and social support status among women with breast cancer in Ethiopia.
    PLoS One. 2021;16:e0257163.
    PubMed     Abstract available


  106. YOSHIKAWA K, Ishida M, Yanai H, Tsuta K, et al
    Immunohistochemical comparison of three programmed death-ligand 1 (PD-L1) assays in triple-negative breast cancer.
    PLoS One. 2021;16:e0257860.
    PubMed     Abstract available


  107. MEKONEN S, Ibrahim M, Astatkie H, Abreha A, et al
    Exposure to organochlorine pesticides as a predictor to breast cancer: A case-control study among Ethiopian women.
    PLoS One. 2021;16:e0257704.
    PubMed     Abstract available


  108. CASELLI E, Pelliccia C, Teti V, Bellezza G, et al
    Looking for more reliable biomarkers in breast cancer: Comparison between routine methods and RT-qPCR.
    PLoS One. 2021;16:e0255580.
    PubMed     Abstract available


  109. CIRIA-SUAREZ L, Jimenez-Fonseca P, Palacin-Lois M, Antonanzas-Basa M, et al
    Breast cancer patient experiences through a journey map: A qualitative study.
    PLoS One. 2021;16:e0257680.
    PubMed     Abstract available


  110. OLAYA-GALAN NN, Salas-Cardenas SP, Rodriguez-Sarmiento JL, Ibanez-Pinilla M, et al
    Risk factor for breast cancer development under exposure to bovine leukemia virus in Colombian women: A case-control study.
    PLoS One. 2021;16:e0257492.
    PubMed     Abstract available


  111. HADJIPANTELI A, Polyviou P, Kyriakopoulos I, Genagritis M, et al
    Comparison of two-view versus single-view digital breast tomosynthesis and 2D-mammography in breast cancer surveillance imaging.
    PLoS One. 2021;16:e0256514.
    PubMed     Abstract available


  112. SANI L, Vispa A, Loretoni R, Duranti M, et al
    Breast lesion detection through MammoWave device: Empirical detection capability assessment of microwave images' parameters.
    PLoS One. 2021;16:e0250005.
    PubMed     Abstract available


  113. JARM K, Kadivec M, Sval C, Hertl K, et al
    Quality assured implementation of the Slovenian breast cancer screening programme.
    PLoS One. 2021;16:e0258343.
    PubMed     Abstract available


  114. SAKSORNCHAI K, Jaruthien T, Nantavithya C, Shotelersuk K, et al
    Long-term results of hypofractionation with concomitant boost in patients with early breast cancer: A prospective study.
    PLoS One. 2021;16:e0258186.
    PubMed     Abstract available


  115. GARCIA MT, Mota BS, Cardoso N, Martimbianco ALC, et al
    Accuracy of frozen section in intraoperative margin assessment for breast-conserving surgery: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0248768.
    PubMed     Abstract available


  116. XIE Y, Guo B, Zhang R
    Cost-effectiveness analysis of radiotherapy techniques for whole breast irradiation.
    PLoS One. 2021;16:e0248220.
    PubMed     Abstract available


  117. MOHAMED RI, Bargal SA, Mekawy AS, El-Shiekh I, et al
    The overexpression of DNA repair genes in invasive ductal and lobular breast carcinomas: Insights on individual variations and precision medicine.
    PLoS One. 2021;16:e0247837.
    PubMed     Abstract available


  118. PARK JH, Jung YS, Kim JY, Bae SH, et al
    Determinants of quality of life in women immediately following the completion of primary treatment of breast cancer: A cross-sectional study.
    PLoS One. 2021;16:e0258447.
    PubMed     Abstract available


  119. STONE JK, Vukadin L, Ahn EE
    eNEMAL, an enhancer RNA transcribed from a distal MALAT1 enhancer, promotes NEAT1 long isoform expression.
    PLoS One. 2021;16:e0251515.
    PubMed     Abstract available


  120. ZOELLER JJ, Press MF, Selfors LM, Dering J, et al
    Clinical evaluation of BCL-2/XL levels pre- and post- HER2-targeted therapy.
    PLoS One. 2021;16:e0251163.
    PubMed     Abstract available


  121. BLASI MA, Maceroni M, Caputo CG, Sammarco MG, et al
    Clinical and ultrasonographic features of choroidal metastases based on primary cancer site: Long-term experience in a single center.
    PLoS One. 2021;16:e0249210.
    PubMed     Abstract available


  122. JAMES JE, Riddle L, Koenig BA, Joseph G, et al
    The limits of personalization in precision medicine: Polygenic risk scores and racial categorization in a precision breast cancer screening trial.
    PLoS One. 2021;16:e0258571.
    PubMed     Abstract available


  123. OPOKU F, Bedu-Addo K, Titiloye NA, Atta Manu E, et al
    Expression profile of tumour suppressor protein p53 and its regulator MDM2 in a cohort of breast cancer patients in a Tertiary Hospital in Ghana.
    PLoS One. 2021;16:e0258543.
    PubMed     Abstract available


  124. JENSEN MD, Hansen KM, Siersma V, Brodersen J, et al
    Using a Deliberative Poll on breast cancer screening to assess and improve the decision quality of laypeople.
    PLoS One. 2021;16:e0258869.
    PubMed     Abstract available


  125. BROCK EJ, Jackson RM, Boerner JL, Li Q, et al
    Sprouty4 negatively regulates ERK/MAPK signaling and the transition from in situ to invasive breast ductal carcinoma.
    PLoS One. 2021;16:e0252314.
    PubMed     Abstract available


  126. AGODIRIN O, Olatoke S, Rahman G, Kolawole O, et al
    Determinants of late detection and advanced-stage diagnosis of breast cancer in Nigeria.
    PLoS One. 2021;16:e0256847.
    PubMed     Abstract available


  127. MARES AG, Pacassoni G, Marti JS, Pujals S, et al
    Formulation of tunable size PLGA-PEG nanoparticles for drug delivery using microfluidic technology.
    PLoS One. 2021;16:e0251821.
    PubMed     Abstract available


  128. AMIRFALLAH A, Knutsdottir H, Arason A, Hilmarsdottir B, et al
    Hsa-miR-21-3p associates with breast cancer patient survival and targets genes in tumor suppressive pathways.
    PLoS One. 2021;16:e0260327.
    PubMed     Abstract available


  129. QIU P, Guo Q, Yao Q, Chen J, et al
    Hsa-mir-3163 and CCNB1 may be potential biomarkers and therapeutic targets for androgen receptor positive triple-negative breast cancer.
    PLoS One. 2021;16:e0254283.
    PubMed     Abstract available


  130. HANSEN JA, Naghavi-Behzad M, Gerke O, Baun C, et al
    Diagnosis of bone metastases in breast cancer: Lesion-based sensitivity of dual-time-point FDG-PET/CT compared to low-dose CT and bone scintigraphy.
    PLoS One. 2021;16:e0260066.
    PubMed     Abstract available


  131. WU WP, Chen CY, Lee CW, Wu HK, et al
    Impact of pre-operative breast magnetic resonance imaging on contralateral synchronous and metachronous breast cancer detection-A case control comparison study with 1468 primary operable breast cancer patients with mean follow-up of 102 months.
    PLoS One. 2021;16:e0260093.
    PubMed     Abstract available


  132. DARGA EP, Dolce EM, Fang F, Kidwell KM, et al
    PD-L1 expression on circulating tumor cells and platelets in patients with metastatic breast cancer.
    PLoS One. 2021;16:e0260124.
    PubMed     Abstract available


  133. MEKONEN S, Ibrahim M, Astatkie H, Abreha A, et al
    Correction: Exposure to organochlorine pesticides as a predictor to breast cancer: A case-control study among Ethiopian women.
    PLoS One. 2021;16:e0260106.
    PubMed     Abstract available


  134. EZZALFANI M, Porcher R, Savignoni A, Delaloge S, et al
    Addressing the issue of bias in observational studies: Using instrumental variables and a quasi-randomization trial in an ESME research project.
    PLoS One. 2021;16:e0255017.
    PubMed     Abstract available


  135. KAGAYA Y, Arikawa M, Sekiyama T, Mitsuwa H, et al
    The concept of "whole perforator system" in the lateral thoracic region for latissimus dorsi muscle-preserving large flaps: An anatomical study and case series.
    PLoS One. 2021;16:e0256962.
    PubMed     Abstract available


  136. PRATOOMCHART C, Klunklin P, Wanwilairat S, Nobnop W, et al
    The advantages of abdominal compression with shallow breathing during left-sided postmastectomy radiotherapy by Helical TomoTherapy.
    PLoS One. 2021;16:e0254934.
    PubMed     Abstract available


  137. HE Q, Cheng G, Ju H
    BCDnet: Parallel heterogeneous eight-class classification model of breast pathology.
    PLoS One. 2021;16:e0253764.
    PubMed     Abstract available


  138. GUO Y, Duan X, Wang C, Guo H, et al
    Segmentation and recognition of breast ultrasound images based on an expanded U-Net.
    PLoS One. 2021;16:e0253202.
    PubMed     Abstract available


  139. GHANBARI S, Salimi A, Rahmani S, Nafissi N, et al
    miR-361-5p as a promising qRT-PCR internal control for tumor and normal breast tissues.
    PLoS One. 2021;16:e0253009.
    PubMed     Abstract available


  140. HARTMANN B, Muller M, Seyler L, Bauerle T, et al
    Feasibility of deuterium magnetic resonance spectroscopy of 3-O-Methylglucose at 7 Tesla.
    PLoS One. 2021;16:e0252935.
    PubMed     Abstract available


  141. EASLEY TO, Ren Z, Kim B, Karczmar GS, et al
    Enhancement-constrained acceleration: A robust reconstruction framework in breast DCE-MRI.
    PLoS One. 2021;16:e0258621.
    PubMed     Abstract available


  142. MARRIE RA, Walld R, Bolton JM, Sareen J, et al
    Effect of comorbid mood and anxiety disorders on breast and cervical cancer screening in immune-mediated inflammatory disease.
    PLoS One. 2021;16:e0249809.
    PubMed     Abstract available


  143. BRUCKMANN NM, Kirchner J, Morawitz J, Umutlu L, et al
    Prospective comparison of CT and 18F-FDG PET/MRI in N and M staging of primary breast cancer patients: Initial results.
    PLoS One. 2021;16:e0260804.
    PubMed     Abstract available


  144. ADEYEMI OJ, Gill TL, Paul R, Huber LB, et al
    Evaluating the association of self-reported psychological distress and self-rated health on survival times among women with breast cancer in the U.S.
    PLoS One. 2021;16:e0260481.
    PubMed     Abstract available


  145. CHOI W, Lee H
    Identifying disease-gene associations using a convolutional neural network-based model by embedding a biological knowledge graph with entity descriptions.
    PLoS One. 2021;16:e0258626.
    PubMed     Abstract available


  146. ALACHRAM H, Chereda H, Beissbarth T, Wingender E, et al
    Text mining-based word representations for biomedical data analysis and protein-protein interaction networks in machine learning tasks.
    PLoS One. 2021;16:e0258623.
    PubMed     Abstract available


  147. SHAMMOUT ODA, Ashmawy NS, Shakartalla SB, Altaie AM, et al
    Comparative sphingolipidomic analysis reveals significant differences between doxorubicin-sensitive and -resistance MCF-7 cells.
    PLoS One. 2021;16:e0258363.
    PubMed     Abstract available


  148. KEETILE M, Ndlovu K, Letamo G, Disang M, et al
    Factors associated with and socioeconomic inequalities in breast and cervical cancer screening among women aged 15-64 years in Botswana.
    PLoS One. 2021;16:e0255581.
    PubMed     Abstract available


  149. LENG X, Huang G, Li S, Yao M, et al
    Correlation of breast cancer microcirculation construction with tumor stem cells (CSCs) and epithelial-mesenchymal transition (EMT) based on contrast-enhanced ultrasound (CEUS).
    PLoS One. 2021;16:e0261138.
    PubMed     Abstract available


  150. SON Y, Han K, Lee YS, Yu J, et al
    Privacy-preserving breast cancer recurrence prediction based on homomorphic encryption and secure two party computation.
    PLoS One. 2021;16:e0260681.
    PubMed     Abstract available


  151. POLITI MC, Saunders CH, Grabinski VF, Yen RW, et al
    An absence of equipoise: Examining surgeons' decision talk during encounters with women considering breast cancer surgery.
    PLoS One. 2021;16:e0260704.
    PubMed     Abstract available


  152. ZHOU Z, Li J, Wang H, Luan Z, et al
    Upper limb rehabilitation system based on virtual reality for breast cancer patients: Development and usability study.
    PLoS One. 2021;16:e0261220.
    PubMed     Abstract available


  153. FOMITCHEVA-KHARTCHENKO A, Rapsomaniki MA, Sobottka B, Schraml P, et al
    Spatial protein heterogeneity analysis in frozen tissues to evaluate tumor heterogeneity.
    PLoS One. 2021;16:e0259332.
    PubMed     Abstract available


  154. ZIMMERMANN RC, Sardiu ME, Manton CA, Miah MS, et al
    Perturbation of BRMS1 interactome reveals pathways that impact metastasis.
    PLoS One. 2021;16:e0259128.
    PubMed     Abstract available


  155. SUN Y, Ji Y
    AAWS-Net: Anatomy-aware weakly-supervised learning network for breast mass segmentation.
    PLoS One. 2021;16:e0256830.
    PubMed     Abstract available


  156. BREDNO J, Lipson J, Venn O, Aravanis AM, et al
    Clinical correlates of circulating cell-free DNA tumor fraction.
    PLoS One. 2021;16:e0256436.
    PubMed     Abstract available


  157. HE X, Anthony DC, Catoni Z, Cao W, et al
    Pulmonary tumor embolism: A retrospective study over a 30-year period.
    PLoS One. 2021;16:e0255917.
    PubMed     Abstract available


  158. LIN KH, Hsu HM, Hsu KF, Chu CH, et al
    Survival outcomes in elderly Taiwanese women according to breast cancer subtype and lymph node status: A single-center retrospective study.
    PLoS One. 2021;16:e0261258.
    PubMed     Abstract available


  159. HU Y, Zou D
    Combined mRNAs and clinical factors model on predicting prognosis in patients with triple-negative breast cancer.
    PLoS One. 2021;16:e0260811.
    PubMed     Abstract available


  160. AWODUTIRE PO, Balogun OS, Olapade AK, Nduka EC, et al
    The modified beta transmuted family of distributions with applications using the exponential distribution.
    PLoS One. 2021;16:e0258512.
    PubMed     Abstract available


  161. CHANG YY, Lin HJ, Hsiao LC, Lin YF, et al
    Reduction of breast tumor drug resistance by 2,3,5,4'-tetrahydroxystilbene for exhibition synergic chemotherapeutic effect.
    PLoS One. 2021;16:e0260533.
    PubMed     Abstract available


  162. TANAKA M, Tanaka T, Takamatsu M, Shibue C, et al
    Effects of the Kampo medicine Yokukansan for perioperative anxiety and postoperative pain in women undergoing breast surgery: A randomized, controlled trial.
    PLoS One. 2021;16:e0260524.
    PubMed     Abstract available


  163. KAUR P, Nagar S, Bhagwat M, Uddin M, et al
    Activated heme synthesis regulates glycolysis and oxidative metabolism in breast and ovarian cancer cells.
    PLoS One. 2021;16:e0260400.
    PubMed     Abstract available


  164. ZHANG X, Kschischo M
    MFmap: A semi-supervised generative model matching cell lines to tumours and cancer subtypes.
    PLoS One. 2021;16:e0261183.
    PubMed     Abstract available


  165. OZGENCIL M, Barwell J, Tischkowitz M, Izatt L, et al
    Assessing BRCA1 activity in DNA damage repair using human induced pluripotent stem cells as an approach to assist classification of BRCA1 variants of uncertain significance.
    PLoS One. 2021;16:e0260852.
    PubMed     Abstract available


  166. HIRAMOTO S, Asano H, Miyamoto T, Takegami M, et al
    Risk factors and pharmacotherapy for chemotherapy-induced peripheral neuropathy in paclitaxel-treated female cancer survivors: A retrospective study in Japan.
    PLoS One. 2021;16:e0261473.
    PubMed     Abstract available


    January 2020
  167. HONG S, Youk T, Lee SJ, Kim KM, et al
    Bone metastasis and skeletal-related events in patients with solid cancer: A Korean nationwide health insurance database study.
    PLoS One. 2020;15:e0234927.
    PubMed     Abstract available


  168. HARATI R, Hafezi S, Mabondzo A, Tlili A, et al
    Silencing miR-202-3p increases MMP-1 and promotes a brain invasive phenotype in metastatic breast cancer cells.
    PLoS One. 2020;15:e0239292.
    PubMed     Abstract available


  169. GUO A, Drake BF, Khan YM, Langabeer Ii JR, et al
    Time-series cardiovascular risk factors and receipt of screening for breast, cervical, and colon cancer: The Guideline Advantage.
    PLoS One. 2020;15:e0236836.
    PubMed     Abstract available


  170. ROSEN S, Brisson BK, Durham AC, Munroe CM, et al
    Intratumoral collagen signatures predict clinical outcomes in feline mammary carcinoma.
    PLoS One. 2020;15:e0236516.
    PubMed     Abstract available


  171. LELLUPITIYAGE DON SS, Robertson KL, Lin HH, Labriola C, et al
    Nobiletin affects circadian rhythms and oncogenic characteristics in a cell-dependent manner.
    PLoS One. 2020;15:e0236315.
    PubMed     Abstract available


  172. PORCIELLO G, Montagnese C, Crispo A, Grimaldi M, et al
    Mediterranean diet and quality of life in women treated for breast cancer: A baseline analysis of DEDiCa multicentre trial.
    PLoS One. 2020;15:e0239803.
    PubMed     Abstract available



  173. Retraction: Role of Activated Rac1/Cdc42 in Mediating Endothelial Cell Proliferation and Tumor Angiogenesis in Breast Cancer.
    PLoS One. 2020;15:e0240575.
    PubMed    



  174. Retraction: Inhibition of endothelial cell proliferation and tumor angiogenesis by up-regulating NDRG2 expression in breast cancer cells.
    PLoS One. 2020;15:e0240574.
    PubMed    


  175. SOLIMAN SSM, Alhamidi TB, Abdin S, Almehdi AM, et al
    Effective targeting of breast cancer cells (MCF7) via novel biogenic synthesis of gold nanoparticles using cancer-derived metabolites.
    PLoS One. 2020;15:e0240156.
    PubMed     Abstract available


  176. DELARMELINA E, Buzelin MA, Souza BS, Souto FM, et al
    High positivity values for bovine leukemia virus in human breast cancer cases from Minas Gerais, Brazil.
    PLoS One. 2020;15:e0239745.
    PubMed     Abstract available


  177. SONG JH, Eum DY, Park SY, Jin YH, et al
    Inhibitory effect of ginsenoside Rg3 on cancer stemness and mesenchymal transition in breast cancer via regulation of myeloid-derived suppressor cells.
    PLoS One. 2020;15:e0240533.
    PubMed     Abstract available


  178. RODRIGUEZ NM, Casanova F, Pages G, Claure L, et al
    Community-based participatory design of a community health worker breast cancer training intervention for South Florida Latinx farmworkers.
    PLoS One. 2020;15:e0240827.
    PubMed     Abstract available



  179. Correction: Trastuzumab effects depend on HER2 phosphorylation in HER2-negative breast cancer cell lines.
    PLoS One. 2020;15:e0241089.
    PubMed     Abstract available


  180. MOSAYEBI A, Mojaradi B, Bonyadi Naeini A, Khodadad Hosseini SH, et al
    Modeling and comparing data mining algorithms for prediction of recurrence of breast cancer.
    PLoS One. 2020;15:e0237658.
    PubMed     Abstract available


  181. PARK SH, Jeong YM, Lee HY, Kim EY, et al
    Opportunistic use of chest CT for screening osteoporosis and predicting the risk of incidental fracture in breast cancer patients: A retrospective longitudinal study.
    PLoS One. 2020;15:e0240084.
    PubMed     Abstract available


  182. CHA YJ, Koo JS
    Expression of EMP1, EMP2, and EMP3 in breast phyllodes tumors.
    PLoS One. 2020;15:e0238466.
    PubMed     Abstract available


  183. SHARMA D, Cartar H, Law N, Giles A, et al
    Optimization of microbubble enhancement of hyperthermia for cancer therapy in an in vivo breast tumour model.
    PLoS One. 2020;15:e0237372.
    PubMed     Abstract available


  184. ZHANG C, Zhao J, Niu J, Li D, et al
    New convolutional neural network model for screening and diagnosis of mammograms.
    PLoS One. 2020;15:e0237674.
    PubMed     Abstract available


  185. YEASMEEN T, Kelaher M, Brotherton JML, Malloy MJ, et al
    Understanding the participation of breast screening among women born in predominantly Muslim countries living in Victoria, Australia from record-linkage data.
    PLoS One. 2020;15:e0237341.
    PubMed     Abstract available


  186. DAHMANI Z, Addou-Klouche L, Gizard F, Dahou S, et al
    Metformin partially reverses the inhibitory effect of co-culture with ER-/PR-/HER2+ breast cancer cells on biomarkers of monocyte antitumor activity.
    PLoS One. 2020;15:e0240982.
    PubMed     Abstract available


  187. LEE SB, Gwark SC, Kang CM, Sohn G, et al
    The effects of poloxamer and sodium alginate mixture (Guardix-SG(R)) on range of motion after axillary lymph node dissection: A single-center, prospective, randomized, double-blind pilot study.
    PLoS One. 2020;15:e0238284.
    PubMed     Abstract available


  188. BAIO G, Fabbi M, Cilli M, Rosa F, et al
    Manganese-enhanced MRI (MEMRI) in breast and prostate cancers: Preliminary results exploring the potential role of calcium receptors.
    PLoS One. 2020;15:e0224414.
    PubMed     Abstract available


  189. ESPANOL AJ, Salem A, Di Bari M, Cristofaro I, et al
    The metronomic combination of paclitaxel with cholinergic agonists inhibits triple negative breast tumor progression. Participation of M2 receptor subtype.
    PLoS One. 2020;15:e0226450.
    PubMed     Abstract available


  190. BARTLETT JMS, Bayani J, Kornaga EN, Danaher P, et al
    Computational approaches to support comparative analysis of multiparametric tests: Modelling versus Training.
    PLoS One. 2020;15:e0238593.
    PubMed     Abstract available


  191. TRACY JK, Adetunji F, Al Kibria GM, Swanberg JE, et al
    Cancer-work management: Hourly and salaried wage women's experiences managing the cancer-work interface following new breast cancer diagnosis.
    PLoS One. 2020;15:e0241795.
    PubMed     Abstract available


  192. BODILY WR, Shirts BH, Walsh T, Gulsuner S, et al
    Effects of germline and somatic events in candidate BRCA-like genes on breast-tumor signatures.
    PLoS One. 2020;15:e0239197.
    PubMed     Abstract available


  193. LUO CY, Natividad RJ, Lalli ML, Asthagiri AR, et al
    Multivariate relationships among nucleus and Golgi properties during fibrillar migration are robust to and unchanged by epithelial-to-mesenchymal transition.
    PLoS One. 2020;15:e0239188.
    PubMed     Abstract available


  194. HUANG JS, Pan HB, Yang TL, Hung BH, et al
    Kinetic patterns of benign and malignant breast lesions on contrast enhanced digital mammogram.
    PLoS One. 2020;15:e0239271.
    PubMed     Abstract available


  195. CUI P, Chen Y, Waili N, Li Y, et al
    Associations of serum C-peptide and insulin-like growth factor binding proteins-3 with breast cancer deaths.
    PLoS One. 2020;15:e0242310.
    PubMed     Abstract available


  196. CRESPO J, Sun H, Wu J, Ding QQ, et al
    Rate of reclassification of HER2-equivocal breast cancer cases to HER2-negative per the 2018 ASCO/CAP guidelines and response of HER2-equivocal cases to anti-HER2 therapy.
    PLoS One. 2020;15:e0241775.
    PubMed     Abstract available


  197. BAJAJ R, Tripathi R, Sridhar TS, Korlimarla A, et al
    Prognostic role of microRNA 182 and microRNA 18a in locally advanced triple negative breast cancer.
    PLoS One. 2020;15:e0242190.
    PubMed     Abstract available


  198. MO W, Ding Y, Zhao S, Zou D, et al
    Identification of a 6-gene signature for the survival prediction of breast cancer patients based on integrated multi-omics data analysis.
    PLoS One. 2020;15:e0241924.
    PubMed     Abstract available


  199. LIN H, Wu Y, Liang G, Chen L, et al
    Establishing a predicted model to evaluate prognosis for initially diagnosed metastatic Her2-positive breast cancer patients and exploring the benefit from local surgery.
    PLoS One. 2020;15:e0242155.
    PubMed     Abstract available


  200. CHANG TC, Matossian MD, Elliott S, Burks HE, et al
    Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor.
    PLoS One. 2020;15:e0226464.
    PubMed     Abstract available


  201. BERA A, Subramanian M, Karaian J, Eklund M, et al
    Functional role of vitronectin in breast cancer.
    PLoS One. 2020;15:e0242141.
    PubMed     Abstract available


  202. WANANDI SI, Limanto A, Yunita E, Syahrani RA, et al
    In silico and in vitro studies on the anti-cancer activity of andrographolide targeting survivin in human breast cancer stem cells.
    PLoS One. 2020;15:e0240020.
    PubMed     Abstract available


  203. YOSHIKAWA K, Ishida M, Yanai H, Tsuta K, et al
    Adipophilin expression is an independent marker for poor prognosis of patients with triple-negative breast cancer: An immunohistochemical study.
    PLoS One. 2020;15:e0242563.
    PubMed     Abstract available


  204. CHIANG ZC, Chiu YK, Lee CC, Hsu NS, et al
    Preparation and characterization of antibody-drug conjugates acting on HER2-positive cancer cells.
    PLoS One. 2020;15:e0239813.
    PubMed     Abstract available


  205. MATHEWS PM, Robinson SA, Gire A, Baer AN, et al
    Extraglandular ocular involvement and morbidity and mortality in primary Sjogren's Syndrome.
    PLoS One. 2020;15:e0239769.
    PubMed     Abstract available


  206. AFRIN K, Iquebal AS, Karimi M, Souris A, et al
    Directionally dependent multi-view clustering using copula model.
    PLoS One. 2020;15:e0238996.
    PubMed     Abstract available


  207. TESFAW A, Alebachew W, Tiruneh M
    Why women with breast cancer presented late to health care facility in North-west Ethiopia? A qualitative study.
    PLoS One. 2020;15:e0243551.
    PubMed     Abstract available


  208. CARTER KJ, Castro F, Morcos RN
    A method for evaluating breast cancer screening strategies using screen-preventable loss of life.
    PLoS One. 2020;15:e0243113.
    PubMed     Abstract available


  209. ZOU Y, Fineberg S, Pearlman A, Feinman RD, et al
    The effect of a ketogenic diet and synergy with rapamycin in a mouse model of breast cancer.
    PLoS One. 2020;15:e0233662.
    PubMed     Abstract available


  210. DE MEULENAERE V, Descamps B, De Wever O, Vanhove C, et al
    In vivo selection of the MDA-MB-231br/eGFP cancer cell line to obtain a clinically relevant rat model for triple negative breast cancer brain metastasis.
    PLoS One. 2020;15:e0243156.
    PubMed     Abstract available


  211. FADDA M, Chappuis PO, Katapodi MC, Pagani O, et al
    Physicians communicating with women at genetic risk of breast and ovarian cancer: Are we in the middle of the ford between contradictory messages and unshared decision making?
    PLoS One. 2020;15:e0240054.
    PubMed     Abstract available


  212. SHI Y, Gong W, Gong X, Wang P, et al
    Genome-wide DNA methylation analysis of breast cancer MCF-7 / Taxol cells with MeDIP-Seq.
    PLoS One. 2020;15:e0241515.
    PubMed     Abstract available


  213. MAO Y, Zhao Y, Zhang Y, Yang H, et al
    In-depth characterization and comparison of the N-glycosylated proteome of two-dimensional- and three-dimensional-cultured breast cancer cells and xenografted tumors.
    PLoS One. 2020;15:e0243789.
    PubMed     Abstract available


  214. NAGHIBI L, Yazdani M, Momtazi-Borojeni AA, Razazan A, et al
    Preparation of nanoliposomes containing HER2/neu (P5+435) peptide and evaluation of their immune responses and anti-tumoral effects as a prophylactic vaccine against breast cancer.
    PLoS One. 2020;15:e0243550.
    PubMed     Abstract available


  215. DE LA CRUZ-KU G, Chambergo-Michilot D, Torres-Roman JS, Rebaza P, et al
    Neutrophil-to-lymphocyte ratio predicts early mortality in females with metastatic triple-negative breast cancer.
    PLoS One. 2020;15:e0243447.
    PubMed     Abstract available


  216. BAR-SELA G, Cohen I, Avisar A, Loven D, et al
    Circulating blood extracellular vesicles as a tool to assess endothelial injury and chemotherapy toxicity in adjuvant cancer patients.
    PLoS One. 2020;15:e0240994.
    PubMed     Abstract available


  217. MOODLEY J, Constant D, Mwaka AD, Scott SE, et al
    Mapping awareness of breast and cervical cancer risk factors, symptoms and lay beliefs in Uganda and South Africa.
    PLoS One. 2020;15:e0240788.
    PubMed     Abstract available


  218. MOGAKA JJO, Chimbari MJ
    The mediating effects of public genomic knowledge in precision medicine implementation: A structural equation model approach.
    PLoS One. 2020;15:e0240585.
    PubMed     Abstract available


  219. LI X, Plataniotis KN
    How much off-the-shelf knowledge is transferable from natural images to pathology images?
    PLoS One. 2020;15:e0240530.
    PubMed     Abstract available


  220. CIRIA-SUAREZ L, Jimenez-Fonseca P, Palacin-Lois M, Antonanzas-Basa M, et al
    Ascertaining breast cancer patient experiences through a journey map: A qualitative study protocol.
    PLoS One. 2020;15:e0244355.
    PubMed     Abstract available


  221. WANG L, Wang W, Zeng S, Zheng H, et al
    Construction and validation of a 6-gene nomogram discriminating lung metastasis risk of breast cancer patients.
    PLoS One. 2020;15:e0244693.
    PubMed     Abstract available


  222. ZABALLA O, Perez A, Gomez Inhiesto E, Acaiturri Ayesta T, et al
    Identifying common treatments from Electronic Health Records with missing information. An application to breast cancer.
    PLoS One. 2020;15:e0244004.
    PubMed     Abstract available


  223. MOODLEY J, Williams P, Gohla G, Major P, et al
    Variation in breast cancer grading in 1,636 resections assessed using control charts and in silico kappa.
    PLoS One. 2020;15:e0242656.
    PubMed     Abstract available


  224. MEKONNEN BD
    Breast self-examination practice and associated factors among female healthcare workers in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0241961.
    PubMed     Abstract available


  225. WINNARD PT JR, Vesuna F, Muthukumar S, Raman V, et al
    Divergent organ-specific isogenic metastatic cell lines identified using multi-omics exhibit differential drug sensitivity.
    PLoS One. 2020;15:e0242384.
    PubMed     Abstract available


  226. DE LOS CAMPOS G, Pook T, Gonzalez-Reymundez A, Simianer H, et al
    ANOVA-HD: Analysis of variance when both input and output layers are high-dimensional.
    PLoS One. 2020;15:e0243251.
    PubMed     Abstract available


  227. OSAPOETRA LO, Chan W, Tran W, Kolios MC, et al
    Comparison of methods for texture analysis of QUS parametric images in the characterization of breast lesions.
    PLoS One. 2020;15:e0244965.
    PubMed     Abstract available


  228. TOYODA Y, Tabuchi T, Hama H, Morishima T, et al
    Trends in clinical stage distribution and screening detection of cancer in Osaka, Japan: Stomach, colorectum, lung, breast and cervix.
    PLoS One. 2020;15:e0244644.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: